ExploreWatchlistsPricing
  1. JP-listed companies
  2. TERUMO CORPORATION
  3. Financials
  4. Working capital

TERUMO CORPORATION (4543)

Market cap
¥3.35T
P/E ratio
20.2x
Terumo develops medical devices and solutions for heart treatment, clinical care, and blood technology to support healthcare delivery worldwide.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndWorking capital (Million JPY)YoY (%)
Mar 31, 2026460,805+21.20%
Mar 31, 2025380,210+2.33%
Mar 31, 2024371,539+22.82%
Mar 31, 2023302,517+19.58%
Mar 31, 2022252,989+14.57%
Mar 31, 2021220,818+15.71%
Mar 31, 2020190,831+5.38%
Mar 31, 2019181,092+112.26%
Mar 31, 201885,318-39.41%
Mar 31, 2017140,822+10.65%
Mar 31, 2016127,264-3.41%
Mar 31, 2015131,755

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat